secwatch.observer — SEC 8-K summary
======================================

Issuer:     eFFECTOR Therapeutics, Inc. (—)
CIK:        0001828522
Form:       8-K/A
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000950170-24-057131
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 1.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

eFFECTOR Therapeutics enters $50M ATM equity offering with H.C. Wainwright, terminates Cantor agreement
--------------------------------------------------------------------------------

- Entered Sales Agreement with H.C. Wainwright & Co. to sell up to $50M of common stock via ATM offerings.
- Agent will receive a 3.0% commission on gross proceeds from any shares sold under the agreement.
- Terminated prior ATM agreement with Cantor Fitzgerald; 1,075,405 shares had been sold for $9.8M.
- No obligation to sell; sales will be made on Nasdaq Capital Market at prevailing market prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828522/000095017024057131/0000950170-24-057131-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828522/000095017024057131/eftr-20240509.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-057131

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer